Friedman Thea M, Jones Stephen C, Statton Debbie, Murphy George F, Korngold Robert
Kimmel Cancer Center, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.
Biol Blood Marrow Transplant. 2004 Apr;10(4):224-35. doi: 10.1016/j.bbmt.2003.12.303.
Graft-versus-host disease (GVHD) can be induced in lethally irradiated mice after allogeneic bone marrow transplantation between major histocompatibility complex-matched strains expressing multiple minor histocompatibility antigen differences. In the B6 --> BALB.B irradiation model, both CD4(+) and CD8(+) donor T cells have the capacity to mediate lethal GVHD. Previously, CDR3-size spectratyping was used to analyze these T-cell responses at a single early time point (day 5) after transplantation and revealed clonal or oligoclonal expansions of the V beta 2, 4, and 6 to 14 families for the CD4(+) response and of the V beta 4, 6, 8 to 11, and 14 families for the B6 CD8(+) response. Appropriate positive selection of these T-cell receptor V beta-skewed CD4(+) and CD8(+) T-cell subsets and their subsequent transfer into lethally irradiated BALB.B recipients resulted in fatal GVHD induction. In contrast, BALB.B mice transplanted with nonskewed V beta CD4(+) T cells survived, with minimal symptoms of GVHD. This study was undertaken to investigate the evolution of the donor/antihost minor histocompatibility antigen T-cell repertoire responses throughout the course of GVHD development. The results indicated that a number of V beta families were consistently involved throughout the course of GVHD, whereas some V beta families exhibited skewed expansions only in either the early or late stages of disease. In addition, sequence analysis of relevant representative skewed CDR3 bands from the CD4(+) V beta 11(+) and the CD8(+) V beta 14(+) families, both of which exhibited strong consistent responses, demonstrated increased use of the J beta 2.5 and J beta 2.4 segments, respectively, thus identifying the T-cell receptor specificities involved.
在表达多种次要组织相容性抗原差异的主要组织相容性复合体匹配品系之间进行异基因骨髓移植后,可在致死性照射的小鼠中诱导移植物抗宿主病(GVHD)。在B6→BALB.B照射模型中,CD4(+)和CD8(+)供体T细胞均有介导致死性GVHD的能力。此前,CDR3大小谱型分析用于在移植后单个早期时间点(第5天)分析这些T细胞反应,结果显示,对于CD4(+)反应,Vβ2、4以及6至14家族出现克隆性或寡克隆性扩增;对于B6 CD8(+)反应,Vβ4、6、8至11以及14家族出现克隆性或寡克隆性扩增。对这些T细胞受体Vβ偏斜的CD4(+)和CD8(+) T细胞亚群进行适当的阳性选择,并随后将其转移到致死性照射的BALB.B受体中,可诱导致命性GVHD。相比之下,移植了非偏斜Vβ CD4(+) T细胞的BALB.B小鼠存活下来,GVHD症状轻微。本研究旨在调查在GVHD发展过程中供体/抗宿主次要组织相容性抗原T细胞库反应的演变。结果表明,在GVHD整个病程中,多个Vβ家族持续参与,而一些Vβ家族仅在疾病的早期或晚期出现偏斜性扩增。此外,对来自CD4(+) Vβ11(+)和CD8(+) Vβ14(+)家族的相关代表性偏斜CDR3条带进行序列分析,这两个家族均表现出强烈的一致性反应,结果分别显示Jβ2.5和Jβ2.4片段的使用增加,从而确定了所涉及的T细胞受体特异性。